ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,475.09
      0.27%
      US Tech 100
      19,198.40
      -0.41%
      Dow Jones
      39,169.52
      0.13%
      Brent Oil
      86.83
      0.35%
      Bitcoin
      62,602.50
      -0.39%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC
      6. Aeolus Pharmaceuticals Inc (CE) (AOLS)

      7. Aeolus Pharmaceuticals Inc (CE) (AOLS) News

      AOLS

      Aeolus Pharmaceuticals (CE) (AOLS)

      Aeolus Pharmaceuticals Inc (CE)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:USOTC:AOLS
      DateTimeSourceHeadlineSymbolCompany
      03/05/20131:24PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      03/01/20135:01PMEdgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      03/01/20135:01PMEdgar (US Regulatory)Certified Annual Shareholder Report for Management Investment Companies (n-csr)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      02/20/20136:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      02/20/20135:08PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      02/20/20136:02AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      02/20/20136:02AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      02/19/20136:00PMMarketwiredAeolus Pharmaceuticals Announces First Quarter Fiscal Year 2013 Financial ResultsUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      02/19/20135:46PMMarketwiredAeolus Pharmaceuticals Announces $3.2 Million Private Placement FinancingUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      02/19/20135:31PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      02/15/20136:03AMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      01/18/20135:01PMOTC MarketsVenue ChangeUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      01/02/201310:59AMMarketwiredAeolus Pharmaceuticals Announces Fiscal Year 2012 ResultsUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      12/31/20125:21PMEdgar (US Regulatory)Annual Report (10-k)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      11/16/20126:03AMEdgar (US Regulatory)Information Statement - All Other (definitive) (def 14c)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      11/16/20126:03AMEdgar (US Regulatory)Information Statement - All Other (definitive) (DEF 14C)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      11/13/20126:04AMEdgar (US Regulatory)Information Statements (revised) (PRER14C)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      11/13/20126:04AMEdgar (US Regulatory)Information Statements (revised) (prer14c)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      11/06/20124:57PMEdgar (US Regulatory)Proxy Statement - Other Information (preliminary) (pre 14c)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      11/06/20124:57PMEdgar (US Regulatory)Proxy Statement - Other Information (preliminary) (PRE 14C)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      10/17/20128:55AMMarketwiredAeolus' AEOL 10150 Supresses Overexpression of 31 Hypoxia-Related Genes Caused by Radiation ExposureUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      09/06/20128:05AMMarketwiredAeolus Pharmaceuticals Provides Positive Update on FDA MeetingUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      08/29/20121:24PMEdgar (US Regulatory)Confidential Treatment Order (CT ORDER)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      08/17/20121:32PMEdgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      08/14/20125:04PMEdgar (US Regulatory)Quarterly Report (10-Q)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      08/14/20125:02PMMarketwiredAeolus Pharmaceuticals Announces Third Quarter Fiscal Year 2012 Financial ResultsUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      07/30/20128:48AMMarketwiredAeolus Pharmaceuticals Announces AEOL 10150 Diminishes Oxidative Stress and Nerve Damage Following Exposure to Nerve AgentUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      07/17/20129:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      06/01/20128:58AMMarketwiredAeolus Pharmaceuticals Announces AEOL 10150 Reduces Lung Damage After Neupogen(R) Treatment Following Radiation ExposureUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      05/29/201212:14PMEdgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
       Showing the most relevant articles for your search:USOTC:AOLS

      Your Recent History

      AMEX
      PSMJ
      Pacer Swan SOS Moderate ...
      Delayed Upgrade Clock